Search results
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 5 days agoGyre is also considering treatments for chronic obstructive pulmonary disease, or COPD, pulmonary...
Precigen Reports First Quarter 2024 Financial Results and Business Updates
WRBL Columbus· 7 hours ago...recurrent respiratory papillomatosis to be presented at the 2024 ASCO Annual Meeting as a late-breaking oral presentation on June 3rd – – Company to host a conference call on June 3rd following the PRGN-2012 ASCO presentation to discuss in detail the pivotal study results and provide business...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with...
Benzinga· 2 days agoFood and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) as an add-on maintenance treatment for adolescents ...
Ozempic or Bust
The Atlantic· 7 days agoIn the early spring of 2020, Barb Herrera taped a signed note to a wall of her bedroom in Orlando, Florida, just above her pillow. Barb was nearly 60...
Mixed reactions after Cy-Fair ISD board votes to remove controversial topics from several textbooks
KHOU 11 Houston· 5 days agoOn Monday night, board member Natalie Blasingame made the motion to remove chapters that reference...
NYC still giving new contracts for migrant services to controversial provider DocGo
New York Daily News· 5 days agoThe city is continuing to do business with DocGo, inking four new contracts with the controversial...
NYC still giving new contracts for migrant services to DocGo
The Post-Standard· 5 days agoThe city is continuing to do business with DocGo, inking four new contracts with the controversial migrant service provider since late last year even as the company remains under fire over issues ...
